Showing results (461-470 of 501) with videos related to

Sort By:
Pageof 51
EMBO Molecular Medicine|November 24, 2018
PARP-1 regulates DNA repair factor availabilityMatthew J Schiewer, Amy C Mandigo, Nicolas Gordon, et al.
Cell Reports|June 8, 2017
Androgen Receptor Deregulation Drives Bromodomain-Mediated Chromatin Alterations in Prostate CancerAlfonso Urbanucci, Stefan J Barfeld, Ville Kytölä, et al.
The Lancet. Oncology|January 20, 2022
Androgen deprivation therapy use and duration with definitive radiotherapy for localised prostate cancer: an individual patient data meta-analysisAmar U Kishan, Yilun Sun, Holly Hartman, et al.
Neoplasia (New York, N.Y.)|May 1, 2015
Development and validation of a scalable next-generation sequencing system for assessing relevant somatic variants in solid tumorsDaniel H Hovelson, Andrew S McDaniel, Andi K Cani, et al.
European Urology|December 9, 2020
A Systematic Review of the Evidence for the Decipher Genomic Classifier in Prostate CancerNeil K Jairath, Alan Dal Pra, Randy Vince, et al.
European Urology Oncology|April 19, 2024
Prognostic Significance of Immune Cell Infiltration in Muscle-invasive Bladder Cancer Treated with Definitive Chemoradiation: A Secondary Analysis of RTOG 0524 and RTOG 0712Zaker Rana, Sophia C Kamran, Amol C Shetty, et al.
JAMA Network Open|December 29, 2021
Comparison of Response to Definitive Radiotherapy for Localized Prostate Cancer in Black and White Men: A Meta-analysisTing Martin Ma, Tahmineh Romero, Nicholas G Nickols, et al.
JAMA Oncology|May 24, 2019
Association of Black Race With Prostate Cancer-Specific and Other-Cause MortalityRobert T Dess, Holly E Hartman, Brandon A Mahal, et al.
The Lancet. Oncology|March 20, 2025
Hypofractionated radiotherapy for prostate cancer (HYDRA): an individual patient data meta-analysis of randomised trials in the MARCAP consortiumAmar U Kishan, Yilun Sun, Alison C Tree, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 9, 2020
Dose-response with stereotactic body radiotherapy for prostate cancer: A multi-institutional analysis of prostate-specific antigen kinetics and biochemical controlRebecca G Levin-Epstein, Naomi Y Jiang, Xiaoyan Wang, et al.
Pageof 51